Spinal microglia play a key role for creating exaggerated pain following tissues inflammation or injury. Electroacupuncture (EA) can effectively control the exaggerated pain both in humans with inflammatory disease and animals with experimental inflammatory pain. However, little is known about the relationship between spinal glial activation and EA analgesia. Using immunohistochemistry, RT-PCR analysis, and behavioral testing, the present study demonstrated that (1) Unilateral intraarticular injection of CFA produced a robust microglial activation and the up-regulation of the tumor necrosis factor (TNF)-α, interleukin (IL-1β), and IL-6 mRNA levels in the spinal cord; (2) Repeated intrathecal (i.t.) injection of minocycline (100 μg), a microglial inhibitor, or EA stimulation of ipsilateral "Huantiao"(GB30) and "Yanglingquan" (GB34) acupoints significantly suppressed CFA-induced nociceptive behavioral hypersensitivity and spinal microglial activation; (3) Combination of EA with minocycline significantly enhanced the inhibitory effects of EA on allodynia and hyperalgesia. For the first time, these data provide direct evidence for the involvement of spinal microglial functional state in anti-nociception of EA. Thus, anti-neuroinflammatory effect of EA might be considered as one of the mechanisms of its anti-arthritic pain effects, and thereby a multidisciplinary integrated approach to treating symptoms related to arthritis might be raised.
Introduction
Arthritis is a major health care burden, with increasing incidence. Pain is its predominant clinical feature, yet therapy is ineffective for many patients. Nearly all symptomatic patients have use-related pain, 50% or less describe rest pain, and about 30% report night pain. Current recommendations for managing arthritis (rheumatoid, or osteoarthritis), including guidelines published by the American College of Rheumatology and European League of Associations of Rheumatology, focus on relieving pain and maintaining or improving physical function. So controlling pain is an important goal of both pharmacological and non-pharmacological management. However, pharmacological management of arthritis is often ineffective and agents such as non-steroidal anti-inflammatory drugs (NSAIDs) may cause unwanted and dangerous side effects (Berman et al., 2004) . Therefore, effective and safe therapeutic strategy in arthritis is currently an unmet need (Curatolo and Bogduk, 2001) .
Complete Freund's adjuvant (CFA) has been utilized to induce rat arthritic immunopathological disease that displays many of the pathological features of human rheumatoid arthritis (Colpaert, 1987; Schaible et al., 2002) . Following intra-articular injection of CFA, hyperalgesia (augmented pain response to noxious stimulation), allodynia (pain produced by normally non-painful stimulation), and spontaneous pain develop within hours and last for more than 2 weeks in the injected paw (Sluka et al., 1998; Schaible et al., 2002) . It is thought that the exaggerated pain results from peripheral sensitization (increase in sensitivity of nociceptive primary afferent neurons) and central sensitization (hyperexcitability of nociceptive neurons in the central nervous system, CNS) (Ji and Woolf, 2001) . It is well known now that spinal cord glia (microglia and astrocytes) importantly contribute to the development and maintenance of central sensitization (Deleo and Yezierski, 2001; Watkins et al., 2001; Wieseler-Frank et al., 2004) . Peripheral nerve or spinal cord injury, peripheral nerve or tissues inflammation, and bone cancer produce hyperalgesia and allodynia, as well as activation of glia in the spinal cord (Colburn et al., 1999; Ledeboer et al., 2005; Zhang et al., 2005; Sun et al., 2006) . Following inflammation or injury, microglia that are often considered resident macrophages in the CNS, rapidly become less ramified and begin to proliferate. Upon activation, microglia can release a variety
